
Nurse Practitioner, Oncology Nursing
Cleveland, Ohio, United States of America
Connect with the speaker?
Dr. Beth Faiman, PhD, MSN, APN-BC, BMTCN, AOCN, FAAN, FAPO, has become an exemplary leader in bringing critical knowledge of cancer nursing to clinical providers locally and globally. She demonstrates enthusiasm for continuous learning by conducting innovative research and has shown the importance of integrating new medical knowledge into nursing practice. In 2013, Dr. Faiman was co-chair of the 1st Nursing Symposium at the International Myeloma Workshop in Kyoto, Japan, and subsequent conferences, including the 8th Nursing and Allied Health Symposium in Rio de Janeiro, in 2024.
Dr. Faiman is an Adult Nurse Practitioner in the Department of Hematology/Oncology at the Cleveland Clinic in Ohio, and a member of the Case Comprehensive Cancer Center under the Cancer Prevention, Control, and Population Research Program. Her leadership is further exemplified by her role as an editor of several books and author of numerous chapters and papers, including serving as Editor of the 3rd Edition of the Multiple Myeloma Textbook for Nurses (2021) and both Editions of the Blood and Marrow Certification Manual for Nurses (2017, 2023). She has also served on the American Board of Internal Medicine and the American Society of Hematology, further solidifying her influence in the field.
In 2023, Faiman was given the NP/PA Educator of Distinction Award in Multiple Myeloma, and in 2022, Dr. Faiman was named the Top NP in Hematology/Oncology and inducted as an inaugural Fellow of Advanced Practice in Oncology (FAPO). Dr. Faiman is a Distinguished Fellow in the American Academy of Nursing (FAAN) and current Editor-in-Chief of the Journal of the Advanced Practitioner in Oncology. She remains an active author, presenter, mentor, and educator on the topics of hematology, oncology, and supportive cancer care.
Dr. Faiman demonstrates energy for advancing cancer care and immerses herself in national and international programs, services, and leadership work within myeloma and cancer care communities, with research interests that also focus on palliation and symptom management.